NRC Health reports developments in healthcare experience improvement solutions for hospitals and health systems. Its updates cover products and services such as Patient Experience, Market Insights, Reputation, Leader Rounding, and The Governance Institute, a service that provides governance research, education, assessments, conferences, and advisory resources for not-for-profit hospital and health system boards.
Company news commonly includes quarterly operating results, Total Recurring Contract Value disclosures tied to renewable contracts, cash flow and adjusted performance measures, health system partnership expansions, online reputation and consumer insight initiatives, industry recognition, governance publications, and capital allocation actions such as share repurchase authorizations.
National Research (NRC Health) announced its Q2 2024 results and corporate developments. Revenue decreased to $35 million from $36 million in Q2 2023, while earnings per diluted share dropped to $0.26 from $0.29. The company's net indebtedness stood at $42 million, with a total recurring contract value (TRCV) of $138 million as of June 30, 2024.
NRC Health amended its credit agreement, extending the revolving loan facility maturity to May 28, 2027, and modifying term loan conditions. The company has 1.1 million shares remaining in its stock repurchase plan and declared a quarterly cash dividend of $0.12 per share. Additionally, NRC Health acquired NOBL Health for approximately $6 million, adding $2 million in TRCV. The company is also releasing new consumer and employee experience capabilities, as well as a proprietary AI engine.
National Research , dba NRC Health, (NASDAQ:NRC) announced first quarter 2024 results showing strong growth potential. The CEO highlighted the company's competitive edge in healthcare insights and innovative products. Financially, significant investments were made in technology and teams to support new product launches. The company returned $18 million to stockholders and focused on product innovation and growth investments.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.